XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Cash flows from operating activities:    
Net loss $ (203,220) $ (93,644)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 4,684 1,522
Non-cash operating lease costs 8,509 8,125
Amortization of deferred commissions 8,316 7,226
Stock-based compensation, net of amounts capitalized 151,014 20,445
Net amortization (accretion) of premiums (discounts) on investments 13,019 (53)
Other 1,214 (175)
Changes in operating assets and liabilities:    
Accounts receivable 127,179 82,701
Deferred commissions (14,749) (5,544)
Prepaid expenses and other assets (54,357) (8,946)
Accounts payable (1,245) (2,857)
Accrued expenses and other liabilities (6,567) (5,155)
Operating lease liabilities (7,833) (7,587)
Deferred revenue (4,110) (2,650)
Net cash provided by (used in) operating activities 21,854 (6,592)
Cash flows from investing activities:    
Purchases of property and equipment (6,430) (2,033)
Capitalized internal-use software development costs (2,480) (2,189)
Purchases of intangible assets (10,460) (6,000)
Purchases of investments (1,145,670) (253,824)
Sales of investments 384,383 0
Maturities and redemptions of investments 516,588 92,042
Net cash used in investing activities (264,069) (172,004)
Cash flows from financing activities:    
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs 0 478,573
Proceeds from early exercised stock options 0 159
Proceeds from exercise of stock options 41,402 10,872
Proceeds from issuance of common stock under the employee stock purchase plan 26,398 0
Repurchases of early exercised stock options and restricted common stock 0 (30)
Payments of deferred offering costs 0 (105)
Net cash provided by financing activities 67,800 489,469
Effect of exchange rate changes on cash, cash equivalents and restricted cash 19 0
Net increase (decrease) in cash, cash equivalents, and restricted cash (174,396) 310,873
Cash, cash equivalents, and restricted cash—beginning of period 835,193 141,976
Cash, cash equivalents, and restricted cash—end of period 660,797 452,849
Supplemental disclosures of cash flow information:    
Property and equipment included in accounts payable and accrued expenses 3,469 929
Stock-based compensation included in capitalized software development costs 6,210 560
Intangible assets included in accrued expenses and other liabilities 5,039 0
Reconciliation of cash, cash equivalents and restricted cash:    
Total cash, cash equivalents and restricted cash $ 660,797 $ 452,849